The relatıonshıp Between Upper Extremity Exercise Test and Exercise Capacity ın patıents wıth Idiopathic Pulmonary Fibrosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

13 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-25

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary aim of our study was to investigate the relationship between 6PBRT outcome measures and 6MWT, 1MSTST and UULEX outcome measures. The secondary aim is to investigate the predictors of 6PBRT test.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Determination of Functional Exercise Capacity, Respiratory Muscle Endurance in Idiopathic Pulmonary Fibrosis

NCT06668051

Idiopathic Pulmonary Fibrosis Healthy

NOT_YET_RECRUITING

Respiratory Muscle Function, Diaphragm Thickness and Health Related Physical Fitness Parameters in Individuals

NCT04995510

Chronic Obstructive Pulmonary Disease

UNKNOWN

Validity and Reliability of the 6-Minute Pegboard and Ring Test in Interstitial Lung Disease

NCT07122141

Interstitial Lung Diseases (ILD)

ACTIVE_NOT_RECRUITING

Determination of Physical Fitness Level in Bronchiectasis

NCT07121218

Pediatric Patients With Bronchiectasis

RECRUITING

Comparison of Physical Activity Level Between Patients With Bronchiectasis and Healthy Subjects

NCT02550821

Bronchiectasis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Our study was conducted in the Chest Diseases Clinic of Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital. Our study was approved by the Marmara University Faculty of Health Sciences Ethics Committee and was conducted in accordance with the Declaration of Helsinki. Signed informed consent was obtained from the participants.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Idiopathic Pulmonary Fibrosis (IPF)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Our study included subjects who were diagnosed with IPF according to the ATS/ERS/JRS/ALAT guidelines, were over 18 years of age, had not changed their treatment for the last 3 months, and had a stable clinical status for the last 3 months.

Exclusion Criteria

* Subjects with orthopedic comorbidity affecting upper extremity use, neurologic comorbidity, severe postural impairment, uncontrolled cardiac or cardiometabolic comorbidity, newly diagnosed cancer, obstructive pulmonary disease, recent surgery and those who refused to volunteer were excluded.

Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No